We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLG.WS
6376
DELISTED
Allego N.V. Warrants
ALLG.WS
-121
Closed -$45
HCCI
6377
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
-4,581
Closed -$208K
CCV.U
6378
DELISTED
Churchill Capital Corp V Units, each consisting of one share of Class A common stock, and one-fourth of one redeemable warrant
CCV.U
-153
Closed -$1.58K
ELYS
6379
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
-17,009
Closed -$8.2K
THRN
6380
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
-1,351
Closed -$13.8K
RAD
6381
DELISTED
Rite Aid Corporation
RAD
-31,271
Closed -$14K
BTWNU
6382
DELISTED
Bridgetown Holdings Limited Units
BTWNU
-198
Closed -$2.06K
MKUL
6383
DELISTED
Molekule Group, Inc. Common Stock
MKUL
-5,848
Closed -$848
ZYNE
6384
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-2,814
Closed -$3.59K
NATI
6385
DELISTED
National Instruments Corp
NATI
-12,666
Closed -$755K
SAMAU
6386
DELISTED
Schultze Special Purpose Acquisition Corp. II Units
SAMAU
-3
Closed -$33
CGRN
6387
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
-4,398
Closed -$3.12K
SDC
6388
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
-667
Closed -$277
LFAC
6389
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
-101
Closed -$1.1K
CELL
6390
DELISTED
PhenomeX Inc. Common Stock
CELL
-885
Closed -$883
UTRS
6391
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
-193
Closed -$636
EBET
6392
DELISTED
EBET, INC. Common Stock
EBET
-8,874
Closed -$8.52K
CPTN
6393
DELISTED
Cepton, Inc. Common Stock
CPTN
-291
Closed -$1.11K
AXLA
6394
DELISTED
Axcella Health Inc. Common Stock
AXLA
-1,225
Closed -$12.8K
HARP
6395
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
-706
Closed -$2.85K
MOBQ
6396
DELISTED
Mobiquity Technologies, Inc. Common Stock
MOBQ
-2,186
Closed -$1.47K
OTMO
6397
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
-100
Closed -$400
EVLO
6398
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
-3,453
Closed -$13.5K
APTO
6399
DELISTED
Aptose Biosciences, Inc.
APTO
-6
Closed -$526
ACOR
6400
DELISTED
Acorda Therapeutics
ACOR
-41
Closed -$615

Similar funds

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.